Analysts at B. Riley FBR Kept the Same their “Buy” rating for Dycom Industries (DY) with $120 PT; CareDx (CDNA)’s Sentiment Is 6.14

May 23, 2018 - By Michael Collier

Analysts at B. Riley FBR have $120 PT on Dycom Industries (NYSE:DY). B. Riley FBR’s PT gives a potential upside of 29.58% from the company’s last close price. The rating was disclosed to clients in analysts note on 23 May.

CareDx (CDNA) investors sentiment increased to 6.14 in Q4 2017. It’s up 4.26, from 1.88 in 2017Q3. The ratio is positive, as 43 investment managers increased and opened new stock positions, while 7 reduced and sold stakes in CareDx. The investment managers in our database now own: 27.90 million shares, up from 6.43 million shares in 2017Q3. Also, the number of investment managers holding CareDx in top ten stock positions increased from 1 to 4 for an increase of 3. Sold All: 3 Reduced: 4 Increased: 13 New Position: 30.

Investors sentiment increased to 1.01 in Q4 2017. Its up 0.01, from 1 in 2017Q3. It increased, as 34 investors sold Dycom Industries, Inc. shares while 109 reduced holdings. 55 funds opened positions while 89 raised stakes. 29.64 million shares or 4.71% less from 31.11 million shares in 2017Q3 were reported. Kornitzer Cap Management Inc Ks has 59,315 shares. Ngam Advsrs Lp invested in 13,347 shares or 0.02% of the stock. Waddell & Reed Fin Inc owns 0.13% invested in Dycom Industries, Inc. (NYSE:DY) for 537,980 shares. The New York-based Gamco Investors Et Al has invested 0.01% in Dycom Industries, Inc. (NYSE:DY). Asset Management Inc holds 0.01% or 1,851 shares in its portfolio. 75,519 are owned by Lazard Asset Management Limited Liability. New England And Management reported 0.95% of its portfolio in Dycom Industries, Inc. (NYSE:DY). Prudential Incorporated owns 21,490 shares. Dixon Hubard Feinour And Brown Va, Virginia-based fund reported 54,880 shares. Atlantic Grp Inc Ltd Limited Liability Company holds 0% of its portfolio in Dycom Industries, Inc. (NYSE:DY) for 6,060 shares. 221,974 are owned by Emerald Mutual Fund Advisers Tru. Public Employees Retirement Of Ohio holds 0% or 1,358 shares in its portfolio. Weaver C Barksdale & Assoc Incorporated has invested 0.02% in Dycom Industries, Inc. (NYSE:DY). Eagle Boston Inv Mgmt has 160,257 shares for 1.78% of their portfolio. Thompson Siegel And Walmsley Ltd Llc invested in 0.24% or 180,732 shares.

Dycom Industries, Inc. provides specialty contracting services in the United States and Canada. The company has market cap of $2.89 billion. The firm offers various specialty contracting services, such as engineering, construction, maintenance, and installation services comprising placement and splicing of fiber, copper, and coaxial cables to telecommunications providers. It has a 21.54 P/E ratio. It also provides tower construction, lines and antenna installation, and foundation and equipment pad construction for wireless carriers, as well as equipment installation and material fabrication, and site testing services; and installs and maintains customer premise equipment, such as digital video recorders, set top boxes, and modems for cable television system operators.

More notable recent Dycom Industries, Inc. (NYSE:DY) news were published by: which released: “Dycom Industries’ (DY) CEO Steven Nielsen on Q1 2019 Results – Earnings Call Transcript” on May 22, 2018, also with their article: “Pre-Open Movers 05/22: (PLAB) (ACIA) (AAP) Higher; (LBY) (DY) (JCP) Lower (more…)” published on May 22, 2018, published: “New Research Coverage Highlights Apollo Commercial Real Estate Finance, Drive Shack, GlycoMimetics, Dycom …” on May 22, 2018. More interesting news about Dycom Industries, Inc. (NYSE:DY) were released by: and their article: “Mid-Day Market Update: Dycom Industries Falls On Q3 Miss; America’s Car-Mart Shares Gain” published on May 22, 2018 as well as‘s news article titled: “Why Dycom Stock Just Died” with publication date: May 22, 2018.

The stock decreased 0.03% or $0.03 during the last trading session, reaching $92.61. About 271,412 shares traded. Dycom Industries, Inc. (NYSE:DY) has risen 13.44% since May 23, 2017 and is uptrending. It has outperformed by 1.89% the S&P500.

Since March 7, 2018, it had 0 insider purchases, and 1 sale for $284,044 activity. HIGGINS PATRICIA sold $284,044 worth of Dycom Industries, Inc. (NYSE:DY) on Wednesday, March 7.

Among 10 analysts covering Dycom (NYSE:DY), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. Dycom has $137 highest and $52 lowest target. $115.78’s average target is 25.02% above currents $92.61 stock price. Dycom had 36 analyst reports since August 27, 2015 according to SRatingsIntel. DA Davidson upgraded the stock to “Buy” rating in Tuesday, December 15 report. The firm has “Neutral” rating by DA Davidson given on Monday, November 9. The company was maintained on Tuesday, November 21 by Craig Hallum. Stifel Nicolaus maintained the stock with “Buy” rating in Tuesday, November 28 report. The firm has “Buy” rating given on Friday, May 26 by ValuEngine. The stock of Dycom Industries, Inc. (NYSE:DY) has “Buy” rating given on Thursday, March 1 by B. Riley & Co. The rating was maintained by KeyBanc Capital Markets with “Buy” on Wednesday, December 20. FBR Capital maintained Dycom Industries, Inc. (NYSE:DY) rating on Monday, February 12. FBR Capital has “Buy” rating and $132.0 target. The firm has “Buy” rating given on Tuesday, February 13 by Canaccord Genuity. The stock of Dycom Industries, Inc. (NYSE:DY) has “Overweight” rating given on Friday, February 9 by KeyBanc Capital Markets.

More important recent CareDx, Inc (NASDAQ:CDNA) news were published by: which released: “CareDx down 1.8% post Q1 results” on May 11, 2018, also published article titled: “CareDx expands NGS Transplant Product Offerings”, published: “CareDx Reports First Quarter Results” on May 10, 2018. More interesting news about CareDx, Inc (NASDAQ:CDNA) was released by: and their article: “CareDx Activities at American Transplant Congress” with publication date: May 01, 2018.

CareDx, Inc., together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic surveillance solutions for transplant patients in North America, Europe, the Middle East, Africa, and Latin America. The company has market cap of $415.99 million. The firm operates through two divisions, CareDx and Olerup. It currently has negative earnings. The Company’s commercialized testing solution includes the AlloMap heart transplant molecular test , a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function who have a low probability of moderate/severe acute cellular rejection.

Paragon Associates & Paragon Associates Ii Joint Venture holds 5.79% of its portfolio in CareDx, Inc for 948,000 shares. Gagnon Advisors Llc owns 955,758 shares or 5.14% of their US portfolio. Moreover, Gagnon Securities Llc has 4.89% invested in the company for 1.88 million shares. The Virginia-based Thompson Davis & Co. Inc. has invested 3.63% in the stock. Perkins Capital Management Inc, a Minnesota-based fund reported 178,639 shares.

The stock decreased 0.08% or $0.01 during the last trading session, reaching $11.79. About 11,198 shares traded. CareDx, Inc (CDNA) has risen 402.58% since May 23, 2017 and is uptrending. It has outperformed by 391.03% the S&P500.

CareDx, Inc (NASDAQ:CDNA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts